SMTL ID : 8v8j.1 (1 other biounit)

PI3Ka H1047R co-crystal structure with inhibitors in two cryptic pockets (compounds 4 and 5).

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 3.35 Å
Oligo State
hetero-1-1-mer
Ligands
1 x YO4: 2-({(1R)-1-[2-(4,4-dimethylpiperidin-1-yl)-3,6-dimethyl-4-oxo-4H-1-benzopyran-8-yl]ethyl}amino)benzoic acid(Non-covalent)
1 x YOR: N-{(3S)-3-(2-methylphenyl)-6-[(oxetan-3-yl)amino]-1-oxo-2,3-dihydro-1H-isoindol-4-yl}-1-benzothiophene-3-carboxamide(Non-covalent)
1 x YNZ: (2S)-N~1~-[(4P)-2-tert-butyl-4'-methyl[4,5'-bi-1,3-thiazol]-2'-yl]pyrrolidine-1,2-dicarboxamide(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Ketcham, J.M. et al., Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3K alpha Mutant Protein. J.Med.Chem. (2024)
Release Date
2024-03-20
Peptides
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform: A
Phosphatidylinositol 3-kinase regulatory subunit alpha: B
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

Phosphatidylinositol 3-kinase regulatory subunit alpha

Related Entries With Identical Sequence

2rd0.1 | 4a55.1 | 4ovu.1 | 4ovv.1 | 5sw8.1 | 5swg.1 | 5swo.1 | 5swp.1 | 5swr.1 | 5swt.1 | 5sx8.1 | 5sx9.1 | 5sxa.1 | 5sxb.1 | 5sxc.1 | 5sxd.1 | 5sxe.1 | 5sxf.1 | 5sxi.1 | 5sxj.1 | 5sxk.1 | 6nct.1 | 8v8h.1 | 8v8h.2 | 8v8i.1 | 8v8i.2 | 8v8j.2 | 8v8u.1 | 8v8u.2 | 8v8v.1  more...